The primary audience for the guideline is health programme managers, including governmental and non-governmental organizations, and policy makers who are responsible for designing maternal, newborn ...and child health programmes, primarily in low-income settings. The guideline is also aimed at health providers and teaching institutions, to increase knowledge of interventions. Development programmes and organizations supporting women’s empowerment and rights will also find this guideline of use.
more
Gender and security is a complex issue, and this research found that there are different levels of comprehension of what it means in humanitarian and...n> development assistance practice. The aims of the paper are twofold: to raise general awareness about gender and how it relates to security risk management, and to provide practical tools for effective integration of gender-specific considerations to the existing security management practices. Document also available in French and Spanish.
more
Supplement
HIV testing services
December 2016
The guide is divided into 3 sections —the first focuses on the conceptual framework for M&E; the second focuses on six key steps for M&E; and further, the appendix provides additional tools, resources, a...nd projects for M&E. With a comprehensive breakdown of the important approaches as well as a checklist approach to the setting up of a monitoring and evaluation framework, this guide works for almost everyone
more
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire popu...lation of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate use of drugs.
more
Statistical Report | No. 39: 2013
Working Document, September 2017
Joining efforts to control two trelated global epidemics.
54th directing council; 67th session of the regional Committee of WHO for the Americas
CD54/11, Rev. 1, 2 October 2015, Original: Spanish